Corporate Counsel, Relay Therapeutics
$161-230k
Office located in Cambridge, MA
AI-driven drug discovery platform
Open for applications
AI-driven drug discovery platform
201-500 employees
Open for applications
$161-230k
Office located in Cambridge, MA
201-500 employees
Company mission
To create new possibilities in drug discovery focused on precision oncology and genetic disease through its AI and ML-driven computing approaches.
Role
Who you are
- Minimum of 4 years’ corporate legal experience in a high-growth biopharmaceutical company and/or a nationally recognized law firm, with preferably at least two years at a nationally recognized law firm
- J.D. from an accredited law school; active membership in at least one state bar
- Demonstrated expertise in corporate law, including substantial experience with SEC and NASDAQ rules and regulations, corporate governance and corporate finance
- Preference for experience reviewing, drafting, redlining, and negotiating a variety of contracts within the life sciences industry, but not required
- Most importantly, you are recognized as having a high degree of emotional intelligence
- You are a legal advisor and collaborative business partner to your colleagues
- Your colleagues admire your technical legal skills, coupled with business acumen and judgment
- You have an unwavering commitment to personal and professional ethics and integrity
- You take pride in your effective problem-solving skills and your craftmanship
- You are resourceful and able to seamlessly multi-task various matters
- You have excellent written and oral communication skills with strong attention to detail
What the job involves
- As Corporate Counsel, you will report to the Senior Corporate Counsel and will support and lead a wide range of responsibilities on a dynamic legal team
- You will provide counsel on various corporate matters, including SEC reporting, corporate governance, public disclosure, financing, risk management and a variety of other legal and business issues
- You will also partner closely with our clinical development team to support the rapid initiation and execution of clinical trials across Relay Tx’s portfolio
- You will support compliance with SEC and NASDAQ rules and regulations, including filing 10-Ks/Qs, 8-Ks, Section 16 filings, the proxy statement and registration statements
- You will partner closely with and support the clinical development team in all aspects of clinical trial start up and maintenance
- You will draft, review and negotiate clinical trial agreements in support of Relay Tx’s clinical trials as well as independently review and finalize patient informed consent forms and other clinical trial related materials
- You will additionally review, draft and negotiate a wide variety of other agreements in support of Relay Tx’s research and development programs
- You will collaborate with Relay Tx’s investor relations team with external communications, including the corporate website, press releases and investor presentations
- You will provide transactional support on corporate aspects of financing activities and strategic external arrangements
- You will advise on matters related to equity plan administration in collaboration with the finance and people teams
- You will play a key role in overseeing various compliance policies, including our Code of Business Conduct and Ethics and Insider Trading Policy, and driving a culture of compliance throughout the organization
- You will assist in preparation for annual stockholders’ meetings
- You will assist with corporate governance matters and compliance with third-party obligations and advising the management team on these issues, including monitoring trends in corporate governance best practices
Our take
Discovering new drugs is essential in improving how diseases are treated, but existing methods are outdated. Many diseases are highly complex and have so far been impossible to treat with drugs, but developments in AI-driven computing present the potential to change this.
Relay Therapeutics provides an AI-driven drug discovery platform called Dynamo that uses cutting-edge experimental computational approaches to identify disease treatments that have previously been deemed untreatable. The platform's AI approach is driven by a pipeline of therapeutic candidates which hold an initial focus on precision oncology and genetic disease treatment.
AI is being used within the medical industry to aid in a wide variety of scenarios such as facility optimization and automated diagnoses, but Relay Therapeutics has smartly applied it to drug discovery. Through this more targeted approach, the company aims to rapidly develop genetic disease treatments and optimize the process of precision oncology, with plans to expand into further disciplines in the future.
Steph
Company Specialist at Welcome to the Jungle
Insights
9% employee growth in 12 months
Company
Funding (last 2 of 3 rounds)
Dec 2018
$400m
SERIES C
Dec 2017
$63m
SERIES B
Total funding: $520m
Company benefits
- Medical coverage
- Dental coverage
- Vision coverage
- Life, AD&D, and disability insurance
- Flexible spending accounts
- 401K retirements savings
- Commute reimbursements
- Parental benefits
- Time off and vacation
Company HQ
Wellington-Harrington, Cambridge, MA
Leadership
Mark Murcko
(Founder & Board Member)Principal at Disruptive Biomedical, LLC since 2011. Senior Lecturer at the Department of Biological Engineering for MIT since 2012.
Sanjiv Patel
(CEO)Has worked across healthcare; as a Surgeon, Healthcare Management Consultant, and in roles such as Commercial GM, CSO and Global Marketing Head in the pharmaceuticals sector.
Salary benchmarks
We don't have enough data yet to provide salary benchmarks for this role.
Submit your salary to help other candidates with crowdsourced salary estimates.
Share this job
View 1 more job at Relay Therapeutics